190 related articles for article (PubMed ID: 31072407)
1. Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease.
Yuan W; Nie S; Wang H; Xu Q; Jia N
BMC Pulm Med; 2019 May; 19(1):88. PubMed ID: 31072407
[TBL] [Abstract][Full Text] [Related]
2. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
Salpeter SR
Drugs; 2009 Oct; 69(15):2025-33. PubMed ID: 19791824
[TBL] [Abstract][Full Text] [Related]
3. Effect of tiotropium on heart rate variability in stable chronic obstructive pulmonary disease patients.
Wu YK; Huang CY; Yang MC; Huang GL; Chen SY; Lan CC
J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):100-5. PubMed ID: 24840562
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.
Hilleman DE; Malesker MA; Morrow LE; Schuller D
Int J Chron Obstruct Pulmon Dis; 2009; 4():253-63. PubMed ID: 19657399
[TBL] [Abstract][Full Text] [Related]
5. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
Niewoehner DE; Rice K; Cote C; Paulson D; Cooper JA; Korducki L; Cassino C; Kesten S
Ann Intern Med; 2005 Sep; 143(5):317-26. PubMed ID: 16144890
[TBL] [Abstract][Full Text] [Related]
6. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.
Jahnz-Różyk K; Szepiel P
Int J Chron Obstruct Pulmon Dis; 2015; 10():613-23. PubMed ID: 25834420
[TBL] [Abstract][Full Text] [Related]
7. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
Sauer R; Hänsel M; Buhl R; Rubin RA; Frey M; Glaab T
Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
9. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety?
McIvor RA
Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792
[No Abstract] [Full Text] [Related]
10. Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair
Yildiz P; Bayraktaroglu M; Gorgun D; Secik F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2859-2867. PubMed ID: 27920513
[TBL] [Abstract][Full Text] [Related]
11. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
Casaburi R; Mahler DA; Jones PW; Wanner A; San PG; ZuWallack RL; Menjoge SS; Serby CW; Witek T
Eur Respir J; 2002 Feb; 19(2):217-24. PubMed ID: 11866001
[TBL] [Abstract][Full Text] [Related]
12. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Singh S; Loke YK; Furberg CD
JAMA; 2008 Sep; 300(12):1439-50. PubMed ID: 18812535
[TBL] [Abstract][Full Text] [Related]
13. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease.
Sethi S; Cote C
Curr Clin Pharmacol; 2011 Feb; 6(1):48-61. PubMed ID: 21235463
[TBL] [Abstract][Full Text] [Related]
14. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
Halpin DM; Kaplan AG; Russell RK
Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667
[TBL] [Abstract][Full Text] [Related]
15. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
Nagy LB
Orv Hetil; 2015 Aug; 156(31):1246-52. PubMed ID: 26211748
[TBL] [Abstract][Full Text] [Related]
16. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.
Maltais F; O'Donnell D; Gáldiz Iturri JB; Kirsten AM; Singh D; Hamilton A; Tetzlaff K; Zhao Y; Casaburi R
Ther Adv Respir Dis; 2018; 12():1753465818755091. PubMed ID: 29439648
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.
Koehorst-Ter Huurne K; Kort S; van der Palen J; van Beurden WJ; Movig KL; van der Valk P; Brusse-Keizer M
Int J Chron Obstruct Pulmon Dis; 2016; 11():1679-88. PubMed ID: 27555758
[TBL] [Abstract][Full Text] [Related]
18. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.
Saberi F; O'Donnell DE
Treat Respir Med; 2005; 4(4):275-81. PubMed ID: 16086600
[TBL] [Abstract][Full Text] [Related]
19. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?].
Rochat T; Janssens JP
Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
